Table 3. Comparison of variants allele frequency (VAF) for mutations in CTCs detected by targeted sequencing (VAF 1) and digital PCR (VAF 2).
Patient # | Gene | Genomic Position | Ref/Alt | VAF 1 (%) | VAF2 (%) |
---|---|---|---|---|---|
20 | EGFR | Chr7_55259599 | G873R | 3.9 | 0.0 |
ATM | Chr11_108236062 | Q3000* | 4.3 | N.A.a | |
TP53 | Chr17_7578260 | V179M | 7.6 | 7.5 | |
SMAD4 | Chr18_48584594 | Q256L | 4.5 | 0.0 | |
22 | EGFR | Chr7_55249081 | M793I | 20.0 | 17.8 |
24 | MET | Chr7_116411923 | R988C | 7.5 | 7.2 |
FGFR2 | Chr10_123274803 | S372F | 3.3 | 2.6 | |
27 | FGFR2 | Chr10_123279539 | G298D | 5.1 | 4.5 |
32 | FGFR3 | Chr4_1806270 | R399C | 6.1 | 1.7b |
TP53 | Chr17_7579442 | P82L | 4.7 | 4.1 | |
36 | ALK | Chr2_29443646 | P1191S | 12.2 | 12.1 |
aData not available because a TaqMan probe for this mutation was not prepared.
bMutation also detected in matched WBCs.